Indication

Fungal infection of lung

A fungal infection of the lung, or pulmonary mycosis, is a lower respiratory tract disease caused by the inhalation and subsequent proliferation of environmental fungal spores within the pulmonary parenchyma or airways. Read more about Fungal infection of lung

3 drugs 3 manufacturers

Advertisement

Drugs that treat it

Common Fungal infection of lung therapies.

Showing 1–3 of 3 drugs

Filter & compare in the drug finder →Opens the drug finder with Fungal infection of lung preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Fungal infection of lung.

A fungal infection of the lung, or pulmonary mycosis, is a lower respiratory tract disease caused by the inhalation and subsequent proliferation of environmental fungal spores within the pulmonary parenchyma or airways.

It affects both immunocompetent individuals exposed to geographically endemic dimorphic fungi—such as *Histoplasma*, *Coccidioides*, or *Blastomyces*—and immunocompromised or chronically ill patients susceptible to opportunistic pathogens, including *Aspergillus*, *Pneumocystis jirovecii*, and *Cryptococcus*.

Pathophysiologically, the condition is characterized by alveolar and interstitial inflammation, granuloma formation, tissue necrosis, or angioinvasion leading to cavitation and pulmonary infarction.

Manifestations range from asymptomatic colonization and subacute pneumonia to severe, life-threatening respiratory failure marked by fever, cough, chest pain, dyspnea, and hemoptysis.

Personalize your experience

Follow Fungal infection of lung and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it